Abbvie reported $26.51B in Current Assets for its first fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Current Assets Change
ALKERMES ALKS:US USD 1.05B 7.81M
Amgen AMGN:US USD 24.06B 4.74B
AstraZeneca AZN:LN USD 20.22B 693M
Astrazeneca AZN:US USD 20.22B 693M
Biogen BIIB:US USD 9.77B 24.9M
Biomarin Pharmaceutical BMRN:US USD 2.68B 165.1M
Bristol Myers Squibb BMY:US USD 26.8B 3.39B
Coherus Biosciences CHRS:US USD 448.28M 1.49M
Eisai 4523:JP JPY 585.38B 35.57B
Eli Lilly And LLY:US USD 17.64B 524.7M
Endo International Ordinary Shares ENDP:US USD 2.05B 145.74M
Gilead Sciences GILD:US USD 13.9B 723M
GlaxoSmithKline GSK:LN GBP 20.25B 33.94B
Horizon Pharma HZNP:US USD 3.41B 208.92M
Infinity Pharmaceuticals INFI:US USD 49.35M 10.26M
Intercept Pharmaceuticals ICPT:US USD 545.37M 58.36M
JAZZ PHA JAZZ:US USD 2.57B 19.33M
Medtronic MDT:US USD 25.4B 3.26B
Neurocrine Biosciences NBIX:US USD 1.21B 186.2M
Novartis NOVN:VX USD 36.95B 1.19B
Pacira Pharmaceuticals PCRX:US USD 533.41M 7.2M
Perrigo Ordinary Shares PRGO:US USD 2.58B 68.2M
Regeneron Pharmaceuticals REGN:US USD 15.43B 101.3M
Revance Therapeutics RVNC:US USD 415.59M 154.65M
Teva Pharmaceutical Industries TEVA:US USD 11.45B 711M
Ultragenyx Pharmaceutical RARE:US USD 1.01B 334.13M
United Therapeutics UTHR:US USD 3.06B 372.1M
Vertex Pharmaceuticals VRTX:US USD 12.27B 767.5M
Zoetis ZTS:US USD 6.55B 100M